Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Extra

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Nouvelle Revue Francaise D'Hematologie|January 1, 1991
New cytotoxic drugs in clinical developmentJ M Extra, F Rousseau, S Culine, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Phase I study of oxaliplatin in patients with advanced cancerJ M Extra, M Espie, F Calvo, et al.
Bulletin Du Cancer|February 1, 1993
[High dose chemotherapy with autologous bone marrow transplantation in ovarian adenocarcinoma]J M Extra, H Cure, P Viens, et al.
Cancer Research|March 1, 1993
Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusionJ M Extra, F Rousseau, R Bruno, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
5HT3-antagonist receptors: their role in drug-induced emesisV Dieras, J M Extra, M Le Bonniec, et al.
Seminars in Oncology|April 1, 1995
Vinorelbine (Navelbine) in the treatment of breast cancer: the European experienceP Fumoleau, T Delozier, J M Extra, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1987
[Acute myelomonocytic leukemia with abnormal eosinophils]J M Extra, M Marty, F Calvo, et al.
La Revue De Medecine Interne|May 1, 1994
[Metastatic eye neoplasms. Review of the literature apropos of 4 cases]E Raymond, S Walter, F Goldwasser, et al.
Archives D'Anatomie Et De Cytologie Pathologiques|January 1, 1995
[Inflammatory cancer of the breast: review and experience at Saint-Louis hospital]M Espié, J M Extra, A de Roquancourt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 2, 1999
High-dose epirubicin and cyclophosphamide every two weeks as first-line chemotherapy for relapsing metastatic breast cancer patientsP H Cottu, L Zelek, J M Extra, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Nouvelle Revue Francaise D'Hematologie|January 1, 1991
New cytotoxic drugs in clinical developmentJ M Extra, F Rousseau, S Culine, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Phase I study of oxaliplatin in patients with advanced cancerJ M Extra, M Espie, F Calvo, et al.
Bulletin Du Cancer|February 1, 1993
[High dose chemotherapy with autologous bone marrow transplantation in ovarian adenocarcinoma]J M Extra, H Cure, P Viens, et al.
Cancer Research|March 1, 1993
Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusionJ M Extra, F Rousseau, R Bruno, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
5HT3-antagonist receptors: their role in drug-induced emesisV Dieras, J M Extra, M Le Bonniec, et al.
Seminars in Oncology|April 1, 1995
Vinorelbine (Navelbine) in the treatment of breast cancer: the European experienceP Fumoleau, T Delozier, J M Extra, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1987
[Acute myelomonocytic leukemia with abnormal eosinophils]J M Extra, M Marty, F Calvo, et al.
La Revue De Medecine Interne|May 1, 1994
[Metastatic eye neoplasms. Review of the literature apropos of 4 cases]E Raymond, S Walter, F Goldwasser, et al.
Archives D'Anatomie Et De Cytologie Pathologiques|January 1, 1995
[Inflammatory cancer of the breast: review and experience at Saint-Louis hospital]M Espié, J M Extra, A de Roquancourt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 2, 1999
High-dose epirubicin and cyclophosphamide every two weeks as first-line chemotherapy for relapsing metastatic breast cancer patientsP H Cottu, L Zelek, J M Extra, et al.
Pageof 9